Racial Differences Seen in Prostate Cancer Care Quality
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 30, 2025 -- Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared with White men, according to a research letter published online July 24 in JAMA Network Open.
Dawson C. Hill, from the University of Michigan in Ann Arbor, and colleagues examined racial differences in confirmatory testing and potential overtreatment in men with newly diagnosed prostate cancer. The analysis included 8,051 men electing for active surveillance and 5,090 unhealthy men at risk for overtreatment identified from a sample of Medicare beneficiaries (2014 to 2019).
The researchers found that Black race was associated with lower odds of undergoing confirmatory testing within 12 months of diagnosis versus White race (adjusted odds ratio, 0.75), yielding a 6.1 percent decrease in confirmatory testing completion. Black race was associated with lower odds of overtreatment among unhealthy men (adjusted odds ratio, 0.86) compared with White race. Overtreatment was less common in Black men versus White men (adjusted difference, 6.1 percent).
"Our study highlights the importance of understanding the nuanced relationship between utilization and prostate cancer care quality when trying to improve care for underserved communities," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Helping Others Linked to Higher Level of Cognitive Function
THURSDAY, Aug. 21, 2025 -- Helping others, both via formal volunteering and informal helping, is associated with higher levels of cognitive function and slower cognitive decline...
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical...
Work-Related Income Drops for Parents of Children Diagnosed With Type 1 Diabetes
THURSDAY, Aug. 21, 2025 -- Work-related income decreases sharply for mothers and fathers of children diagnosed with type 1 diabetes, with similar effects across sociodemographic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.